Clinical trial
Zoladex Plus Tamoxifen in Breast Cancer
NCT00827307
Study timeline
Study start (unknown)2008-06-01Date precision: month
Registry last updated2011-08-08
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Mammographyunresolved
Estrogenunresolved
Lipemiaunresolved
Endometriumunresolved
Ultrasonographyunresolved
Interventions
tamoxifenDRUG · verified · RxNorm: tamoxifen
GoserelinDRUG · verified · RxNorm: goserelin
Sponsors & collaborators
Zhejiang Cancer Hospitallead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00827307 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.